Osome
Singapore-based online accounting and corporate-compliance service for SMEs.
Osome is cutting losses and chasing profitability while AI tools compress the bookkeeping tasks it sells, and rivals like Sleek and Statrys fight for the same customers.
Osome is a licensed accounting service that handles bookkeeping, tax compliance, and financial questions for small business owners, using software to speed up the work. It is hard to copy because regulators require licenses and liability insurance, but Osome's direct competitors like Sleek and Statrys have the same licenses, funding, and technology, so this protection is not unique. The real threat is that AI tools like ChatGPT and Claude can now do the core tasks Osome charges for, such as sorting receipts and answering tax questions, which is exactly what Osome's business depends on. Whether Osome survives will hinge on whether its new plan to work alongside frontier AI actually attracts more customers or instead makes customers realize they can use the AI directly and skip Osome entirely.
Osome raises new funding or debt before hitting 2027 profitability target. Would show cash pressure and weaker bargaining position against better-funded rivals.
Osome's MCP integration with Claude/ChatGPT/Gemini either drives new signups or gets replicated by Sleek/Statrys. Shows whether the AI feature is a durable edge or a copyable commodity feature.
- FY2025 revenue S$26.6M
- EBITDA losses cut 50% year over year
- Guided 20 to 30% YoY growth, profit target 2027
- Core billable workflow (categorization, reconciliation, compliance Q&A) is the exact target of frontier AI automation.
- No new capital raised since May 2024 while still pre-profitability, ahead of 2027 profitability target.
- Multiple similarly licensed, similarly funded peers (Sleek, Statrys, Grof) contest the same SME segment.
- Conflicting customer satisfaction signals, 4.2/5 self-reported vs 3.4/5 independent Trustpilot rating, July 2026.
- Headcount down 9.6% from 2023 peak despite 2025 rehiring, indicating past restructuring pressure.
| Rival | Direction | Evidence |
|---|---|---|
| Sleek | contesting | Sleek, founded 2017 like Osome, closed a Series B round in June 2025 and runs comparison marketing |
| Statrys | contesting | Statrys publishes a Sleek vs Osome comparison page positioning itself as an alternative, June 2026 |
| Grof | contesting | Grof published a head to head comparison targeting Osome customers, May 2026 |
| Xero | contesting | Osome is a Xero Platinum Partner but Xero retains the ledger, per Osome's own FAQ, Nov 2025 |
- Is Osome profitable in 2026?
- Not yet. Osome reported S$26.6M revenue for FY2025 (year ended 30 April 2025) and cut its EBITDA loss by 50% year on year, per its own July 2026 results release. The company guides to profitability in 2027, not 2026.
- Could AI replace Osome's bookkeeping service?
- Osome's core paid work, receipt categorization, bank reconciliation, and routine compliance Q&A, is exactly what generative AI targets. Osome itself launched a Categorisation AI and an MCP server in July 2026 to let founders query data via Claude, ChatGPT, and Gemini, automating much of its own billable workflow.
- Who is Osome's biggest competitor?
- Sleek is Osome's closest rival in Singapore's digital corporate-services market; both were founded in 2017 and Sleek raised a Series B round in June 2025. Statrys and Grof also run active head-to-head marketing campaigns targeting Osome's customer base as of mid-2026.
- Has Osome raised new funding recently?
- Osome's last disclosed capital raise was a US$17M Series B extension (equity and debt) closed in May 2024. As of July 2026 no newer round has been reported; the company's messaging has shifted toward hitting profitability in 2027 rather than raising fresh capital.
- What is Osome's revenue?
- Osome reported S$26.6M in revenue for the fiscal year ended 30 April 2025, per its own results announcement published 2026-07-03. It has guided to 20 to 30 percent year on year growth for FY2026.
- Who owns Osome?
- Osome is privately held and venture-backed, with no IPO or acquisition on record as of July 2026. Investors from its funding rounds include Target Global, AltaIR Capital, Illuminate Financial, AFG Partners, and Winter Capital.
- 2026-07-03Osome reports FY2025 revenue of S$26.6M, EBITDA loss cut 50% YoY
- 2026-07Osome launches MCP server letting founders query company data via Claude, ChatGPT, Gemini
- 2026-03Osome rebuilds accounting stack into unified AI platform, credited with 100% YoY growth in a cohort
- 2025-06-09New Singapore CSP regulatory requirements on AML/CDD/beneficial ownership take effect
- 2024-05Osome closes US$17M Series B extension (equity and debt)
- 2022-12Osome closes $25M Series B, cumulative funding reaches about $51M
- 2021-06Osome closes $16M Series A, total funding about $24.5M
- 2017Osome founded in Singapore
- Osome Reports S$26.6M FY2025 Revenue, Cuts EBITDA Losses by 50% (2026-07-03)
- Singaporean FinTech Platform Osome Bags US$25M in Series B Funding Round (2022-12-06)
- Osome raises USD 16 mln Series A (2021-06-14)
- Osome Raises US$17M in Series B Funding (2026-06-23)
- cbinsights.com company profile (2026-07-30)
- Osome Raises a $16M Series A (2026-07-21)
- Osome Launches New Tools and Partnerships at Echelon 2025 (2026-07-03)
- Osome homepage (2026-06)
- Osome Singapore Review (2026) (2026-07-13)
- Employee Count & Headcount Data (2026-06-29)
- How Osome Rebuilt Its Accounting Stack with Hybrid AI (2026-03-01)
- Osome Eyes the Next Wave of AI Companies Choosing Singapore (2026-07-26)